US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Skye Bioscience Inc (SKYE) 銘柄情報

Skye Bioscience Inc (SKYE)

0.69

-0.0109

(-1.56%)

終了 7月12日 5:00AM

0.7038

0.0138

(2.00%)

取引時間後: 7:14AM

Skye Bioscience Inc (SKYE) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.7038

( 0.41% )

買値

0.6703

売値

0.6898

出来高

184,958

平均取引量 (3 か月)

US$ 182,125

財務取引量

US$ 128,642

0.6721 日の範囲 0.71

0.5655 52 週間の範囲 4.9902

時価総額

企業価値

7.821M

前日終値

0.7009

始値

0.70

時刻

最終取引時間

VWAP

0.69552

歳入

-

純利益

-57.33M

発行済株式数

35,143,722

浮動株比率 (%)

65.36%

機関投資家保有比率 (%)

45.24%

配当利回り

PER

-0.48

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-1.45

ベータ

2.94

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating ant... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

skyebioscience.com

本社

San Diego, United States

設立

-

Skye Bioscience Inc is listed in the Health Care sector of the ナスダック市場 with ticker SKYE. The last closing price for Skye Bioscience was US$0.70. Over the last year, Skye Bioscience shares have traded in a share price range of US$ 0.5655 to US$ 4.9902.

Skye Bioscience currently has 35,143,722 shares in issue. The market capitalisation of Skye Bioscience is US$24.73 million. Skye Bioscience has a price to earnings ratio (PE ratio) of -0.48.

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0038	0.542857142857	0.7	0.7193	0.69	51532	0.70319881	CS
4	-0.1086	-13.3677991137	0.8124	0.8154	0.67	112422	0.70504196	CS
12	-0.0471	-6.27247303236	0.7509	1.12	0.67	173739	0.81180039	CS
26	-0.3062	-30.3168316832	1.01	1.12	0.5655	361286	0.79761986	CS
52	-3.4962	-83.2428571429	4.2	4.9902	0.5655	490097	1.66883318	CS
156	-12.7962	-94.7866666667	13.5	17.6473	0.5655	459211	2.65838651	CS
260	-12.7962	-94.7866666667	13.5	17.6473	0.5655	459211	2.65838651	CS

SKYE - Frequently Asked Questions (FAQ)

What is the current Skye Bioscience Inc share price?

The current share price of Skye Bioscience Inc is US$ 0.7038

How many Skye Bioscience Inc shares are in issue?

Skye Bioscience Inc has 35,143,722 shares in issue

What is the market cap of Skye Bioscience Inc?

The market capitalisation of Skye Bioscience Inc is USD 24.73M

What is the 1 year trading range for Skye Bioscience Inc share price?

Skye Bioscience Inc has traded in the range of US$ 0.5655 to US$ 4.9902 during the past year

What is the PE ratio of Skye Bioscience Inc?

The price to earnings ratio of Skye Bioscience Inc is -0.48

What is the registered address of Skye Bioscience Inc?

The registered address for Skye Bioscience Inc is 11250 El Camino Real, San Diego, California, 92130

What is the Skye Bioscience Inc website address?

The website address for Skye Bioscience Inc is skyebioscience.com

Ispro

The GSEs’ investors’ Sisyphean saga still comes down to the Senior Preferred Stock (SPS) Liquidation Preference (LP), which grows largely in line with the Twins’ retained earnings.
There is a general misunderstanding that the Twins are currently sending profits back to the US government. This

barnstormer

barnstormer 19分前

Frosty, apples and oranges in my opinion. The 2015 issue was a regulatory non-compliance problem. The current nondisclosure statement is standard, protective, and expected under MHRA rules. If you feel strongly, you should call the SEC. I would be interested in what they say.

Steady_T

Steady_T 29分前

And of course you have absolutely no information to substantiate such a claim of " That is securities fraud plan and simple."

If so, show it. Otherwise call your statements guess, like they are.

AngeloFoca

AngeloFoca 33分前

The fact that nothing was disclosed tells us NWBO did not receive any such letter. It's that simple. To suggest anything else is speculation.
That will not make a difference to him. He's been speculating on that "CHM letter" every post forever... and accusing Linda of fraud based on that s

newflow

newflow 41分前

Not just yours only stox, whoever raised concerns. Its a public forum, i am trying to fill in the gaps of every beneficiary who are in my same situation looking for answers, i dont mislead anyone for my benefit. I wish you and all involved goodluck, it has been a great journey. I dont give up.

surfer44

surfer44 54分前

The 1.7 Billion Warrant Strategy That Will Crush This Gold Bull Market – Collin Kettell”

https://youtu.be/cgT4PZifEb0

FrostyIsland3

FrostyIsland3 56分前

I am inclined to believe that the CHM issued a 2nd RFI to NWBO shortly after the November 2025 meeting. I think NWBO and the MHRA have been wrestling with the 2nd RFI ever since. I think there is a real chance that the CHM issued a CHM Letter and that Linda Powers did not disclose it. This would

bwrbad

bwrbad 58分前

This is what AI anyasis of QS: When a company heavily hypes a world-changing technology, misses its deadlines, and the leaders still get rich while the stock crashes, it feels exactly like a scam to the people who lost money.To be completely clear and unbiased:The Anger is Fully Justified: Executiv

newflow

newflow 59分前

So does Windstream, GNC, LBHI..etc. So whats your point?. You are smarter than AI?. You are not and IMO you have your agenda along with az.

barnstormer

barnstormer 1時間前

Frosty, I think you're wrong for the reason I just laid out in my response to your prior post. But if you and Baxers think Powers and NWBO have violated U.S. securities laws, give the SEC a call Monday and state your case. I'd be interested to hear what they say.

FrostyIsland3

FrostyIsland3 1時間前

Barnstormer, Linda Powers saying that she will not disclose interim guidance while the DCVax-L MAA is pending does not exempt her from US securities laws. The existence of a CHM Letter would be price moving news because it is indisputably material information. Linda Powers is committing securities

JD400

JD400 1時間前

Trump Official CORNED BY SENATE over BRIBERY SCHEME?!

Did they break they mighty bitcoin ?

Jul 11, 2026 Legal AF Podcast
The Senate is taking a hard look at Commerce Secretary Lutnick and whether he violated federal bribery laws concerning mining comp

Steady_T

Steady_T 1時間前

That is a really silly comment. How can anyone who is not in charge, who is not making decisions, be held accountable?

We all make guesses based on inadequate information.
Some are optimistic, some are pessimistic, all are guess.

Lighten up.

JD400

JD400 1時間前

Trump Official CORNED BY SENATE over BRIBERY SCHEME?!

Did they break they mighty bitcoin ?

Jul 11, 2026 Legal AF Podcast
The Senate is taking a hard look at Commerce Secretary Lutnick and whether he violated federal bribery laws concerning mining comp

MightyX

MightyX 1時間前

ron_66271

ron_66271 1時間前

WMI Filed for BK As a Solvent Debtor.

$32 Billion in assets and $8 Billion in liabilities.

~$24 Billion positive equity.

It gets even more crazy when you understand WMIIC

That is pretty simple math from the first two WMI/WMIIC filin

Seminole Red

Seminole Red 1時間前

I dont think Rory likes the weather

barnstormer

barnstormer 1時間前

Frosty, you are correct that Powers and NWBO did not disclose the existence of a CHM Letter. What you apparently forgot to mention or maybe was not aware of is the company stated at the time of the NHRA application in December 2023 “The Company does not intend to make interim announcements while the

newflow

newflow 1時間前

Ron you are misdirecting people. WMI filed with BK court assets and libilities. You better know that.I dont believe you as a matter of fact.

KRISGO

KRISGO 1時間前

Baxer's comment is based on an assumption, and we can't confirm that's actually what happened. I was simply saying that I can understand his perspective to some extent, but we can't claim someone violated the rules when we don't know the facts.
That said, this PSM analysis is very positive a

Kjv

Nah…I had a busy Friday so didn’t post much plus Fridays aren’t usually the best of days anyways.
We can’t deny some people bought on Thursday because they had been tipped off on the imminent news release.
Despite that, we had a decent buy volume and we will continue our trend upwards

Kool Aid Man

Kool Aid Man 2時間前

6,960,000,000 shares have been printed and sold since this ticker was created in 1994...trading hands and renamed twice before becoming HIRU in 2008. Despite being a publicly traded ticker the total market value of those shares is a pathetic

$6.5 million.

Unfortunately

newflow

newflow 2時間前

$299 Billion, why not $299 trillion?.

flipper44

flipper44 2時間前

“StonkMaster
Re: None
Thursday, 07/09/2026 6:12:39 PM
I spoke with GZ today, here are a few things I can share:
1. He confirmed the MHRA now has the full BNOS data analysis….”

I know there are some posters here that are supposedly experts, but I think this

Skye Bioscience

Wisdomtree Wti Crude Oil...

AMC Financial (EM)

VanEck Investments

Contango Income Generator

1.425%26fev48 1.425%26fe...

BNP Paribas Easy MSCI US...

Financial 15 Split (PK)

Essity Aktiebolag (PK)

SIG Oil Exploration and ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。